The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Calcium antagonists for aneurysmal subarachnoid haemorrhage
Open accessAbstract
BACKGROUND: Secondary ischaemia is a frequent cause of poor outcome in patients with subarachnoid haemorrhage (SAH). Its pathogenesis has been incompletely elucidated, but vasospasm probably is a contributing factor. Experimental studies have suggested that calcium antagonists can prevent or reverse vasospasm and have neuroprotective properties. OBJECTIVES: To determine whether calcium antagonists improve outcome in patients with aneurysmal SAH. SEARCH STRATEGY: We searched the Cochrane Stroke Group Trials Register (last searched April 2006), MEDLINE (1966 to March 2006) and EMBASE (1980 to March 2006). We handsearched two Russian journals (1990 to 2003), and contacted trialists and pharmaceutical companies in 1995 and 1996. SELECTION CRITERIA: Randomised controlled trials comparing calcium antagonists with control, or a second calcium antagonist (magnesium sulphate) versus control in addition to another calcium antagonist (nimodipine) in both the intervention and control groups. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted the data and assessed trial quality. Trialists were contacted to obtain missing information. MAIN RESULTS: Sixteen trials, involving 3361 patients, were included in the review; three of the studies were of magnesium sulphate in addition to nimodipine. Overall, calcium antagonists reduced the risk of poor outcome: the relative risk (RR) was 0.81 (95% confidence interval (CI) 0.72 to 0.92); the corresponding number of patients needed to treat was 19 (95% CI 1 to 51). For oral nimodipine alone the RR was 0.67 (95% CI 0.55 to 0.81), for other calcium antagonists or intravenous administration of nimodipine the results were not statistically significant. Calcium antagonists reduced the occurrence of secondary ischaemia and showed a favourable trend for case fatality. For magnesium in addition to standard treatment with nimodipine, the RR was 0.75 (95% CI 0.57 to 1.00) for a poor outcome and 0.66 (95% CI 0.45 to 0.96) for clinical signs of secondary ischaemia. AUTHORS' CONCLUSIONS: Calcium antagonists reduce the risk of poor outcome and secondary ischaemia after aneurysmal SAH. The results for 'poor outcome' depend largely on a single large trial of oral nimodipine; the evidence for other calcium antagonists is inconclusive. The evidence for nimodipine is not beyond all doubt, but given the potential benefits and modest risks of this treatment, oral nimodipine is currently indicated in patients with aneurysmal SAH. Intravenous administration of calcium antagonists cannot be recommended for routine practice on the basis of the present evidence. Magnesium sulphate is a promising agent but more evidence is needed before definite conclusions can be drawn.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage
Allen, G. S., Ahn, H. S., Preziosi, T. J., Battye, R., Boone, S. C., Chou, S. N., Kelly, D. L., Weir, B. K., Crabbe, R. A., Lavik, P. J., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303173081103 · Cited by 1,195
Pickard, J. D., Murray, G. D., Illingworth, R. D., Shaw, M. D. M., Teasdale, G. M., Foy, P. M., Humphrey, P. R. D., Lang, D. A., Nelson, R. J., Richards, P., et al. (1989) · CRC Press eBooks · doi:10.1136/bmj.298.6674.636 · Cited by 1,144
Case-Fatality Rates and Functional Outcome After Subarachnoid Hemorrhage: A Systematic Review
Hop, J. W., Rinkel, G. J. E., Algra, A., & van Gijn, J. (1997) · Stroke · doi:10.1161/01.str.28.3.660 · Cited by 1,093
Self-citationPetruk, K. C., West, M., Mohr, G., Weir, B. K. A., Benoit, B. G., Gentili, F., Disney, L. B., Khan, M. I., Grace, M., Holness, R. O., et al. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.4.0505 · Cited by 549
Shibuya, M., Suzuki, Y., Sugita, K., Saito, I., Sasaki, T., Takakura, K., Nagata, I., Kikuchi, H., Takemae, T., Hidaka, H., et al. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.4.0571 · Cited by 466
Barker, F. G., & Ogilvy, C. S. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.3.0405 · Cited by 358
Haley, E. C., Kassell, N. F., Torner, J. C., & _, _. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.4.0537 · Cited by 351
Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial
van den Bergh, W. M. (2005) · Stroke · doi:10.1161/01.str.0000160801.96998.57 · Cited by 321
Self-citation
Cited by
Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
Greebe, P., Bromberg, J. E., Rinkel, G. J., Algra, A., & van Gijn, J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.273 · Cited by 4,139
Self-citationConnolly, E. S., Rabinstein, A. A., Carhuapoma, J. R., Derdeyn, C. P., Dion, J., Higashida, R. T., Hoh, B. L., Kirkness, C. J., Naidech, A. M., Ogilvy, C. S., et al. (2012) · Stroke · doi:10.1161/str.0b013e3182587839 · Cited by 3,512
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
Nieuwkamp, D. J., Setz, L. E., Algra, A., Linn, F. H., de Rooij, N. K., & Rinkel, G. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70126-7 · Cited by 1,507
Self-citationSubarachnoid haemorrhage: diagnosis, causes and management
van Gijn, J., & Rinkel, G. J. E. (2001) · Brain · doi:10.1093/brain/124.2.249 · Cited by 1,353
Self-citationSpontaneous subarachnoid haemorrhage
Macdonald, R. L., & Schweizer, T. A. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30668-7 · Cited by 1,149
Steiner, T., Juvela, S., Unterberg, A., Jung, C., Forsting, M., & Rinkel, G. (2013) · Cerebrovascular Diseases · doi:10.1159/000346087 · Cited by 1,142
Self-citationDiringer, M. N., Bleck, T. P., Claude Hemphill, J., Menon, D., Shutter, L., Vespa, P., Bruder, N., Connolly, E. S., Citerio, G., Gress, D., et al. (2011) · Neurocritical Care · doi:10.1007/s12028-011-9605-9 · Cited by 1,121
Hoh, B. L., Ko, N. U., Amin-Hanjani, S., Chou, S. H.-Y., Cruz-Flores, S., Dangayach, N. S., Derdeyn, C. P., Du, R., Hänggi, D., Hetts, S. W., et al. (2023) · Stroke · doi:10.1161/str.0000000000000436 · Cited by 1,000
Aneurysmal Subarachnoid Hemorrhage
Suarez, J. I., Tarr, R. W., & Selman, W. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052732 · Cited by 986
Delayed neurological deterioration after subarachnoid haemorrhage
Macdonald, R. L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.246 · Cited by 887
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Macdonald, R. L., Kassell, N. F., Mayer, S., Ruefenacht, D., Schmiedek, P., Weidauer, S., Frey, A., Roux, S., & Pasqualin, A. (2008) · Stroke · doi:10.1161/strokeaha.108.519942 · Cited by 648
Spontaneous subarachnoid haemorrhage
Claassen, J., & Park, S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00938-2 · Cited by 587
Dreier, J. P., Major, S., Manning, A., Woitzik, J., Drenckhahn, C., Steinbrink, J., Tolias, C., Oliveira-Ferreira, A. I., Fabricius, M., Hartings, J. A., et al. (2009) · Brain · doi:10.1093/brain/awp102 · Cited by 545
Aneurysmal Subarachnoid Hemorrhage: the Last Decade
Neifert, S. N., Chapman, E. K., Martini, M. L., Shuman, W. H., Schupper, A. J., Oermann, E. K., Mocco, J., & Macdonald, R. L. (2021) · Translational Stroke Research · doi:10.1007/s12975-020-00867-0 · Cited by 424
Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm
Rowland, M. J., Hadjipavlou, G., Kelly, M., Westbrook, J., & Pattinson, K. T. S. (2012) · British Journal of Anaesthesia · doi:10.1093/bja/aes264 · Cited by 357
Controversies and evolving new mechanisms in subarachnoid hemorrhage
Chen, S., Feng, H., Sherchan, P., Klebe, D., Zhao, G., Sun, X., Zhang, J., Tang, J., & Zhang, J. H. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.002 · Cited by 344
Macdonald, R. L., Higashida, R. T., Keller, E., Mayer, S. A., Molyneux, A., Raabe, A., Vajkoczy, P., Wanke, I., Bach, D., Frey, A., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.648980 · Cited by 344
Vergouwen, M. D., Vermeulen, M., Coert, B. A., Stroes, E. S., & Roos, Y. B. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.74 · Cited by 339
Self-citationMagnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial
van den Bergh, W. M. (2005) · Stroke · doi:10.1161/01.str.0000160801.96998.57 · Cited by 321
Self-citationPathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review
Dodd, W. S., Laurent, D., Dumont, A. S., Hasan, D. M., Jabbour, P. M., Starke, R. M., Hosaka, K., Polifka, A. J., Hoh, B. L., & Chalouhi, N. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021845 · Cited by 315
Geraghty, J. R., & Testai, F. D. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0690-x · Cited by 304
Metamorphosis of Subarachnoid Hemorrhage Research: from Delayed Vasospasm to Early Brain Injury
Sehba, F. A., Pluta, R. M., & Zhang, J. H. (2011) · Molecular Neurobiology · doi:10.1007/s12035-010-8155-z · Cited by 282
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial
Mees, S. M. D., Algra, A., Vandertop, W. P., van Kooten, F., Kuijsten, H. A., Boiten, J., van Oostenbrugge, R. J., Salman, R. A.-S., Lavados, P. M., Rinkel, G. J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60724-7 · Cited by 270
Self-citationThe pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage
Budohoski, K. P., Guilfoyle, M., Helmy, A., Huuskonen, T., Czosnyka, M., Kirollos, R., Menon, D. K., Pickard, J. D., & Kirkpatrick, P. J. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307711 · Cited by 267
Panagiotou, O. A., Contopoulos-Ioannidis, D. G., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f707 · Cited by 89
Metadata
- Authors
- Dorhout Mees, S., Rinkel, G. J., Feigin, V. L., Algra, A., van den Bergh, W. M., Vermeulen, M., & van Gijn, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-07-18
- Volume
- 2008
- Issue
- 4
- Pages
- CD000277-CD000277
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2128973824
- Cited by
- 758
- References
- 25
- FWCI
- 23.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.